chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen again; hot; red; itchy; round; 3.5-inch circular rash; fever; palpitations; swelled up; got a little red; A spontaneous report  was received from a Consumer concerning a 72-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelled up, got a little red, swollen again, hot, itchy, round, 3.5-inch circular rash, fever, palpitations.  The patient's medical history include asthma and diabetes. Concomitant medications reported were inhaler, metformin for use for unknown indication.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced the events swelled up. got a little red. On 29 Jan 2021, the patient experienced the events swollen again. hot, itchy, round, 3.5-inch circular rash, fever, palpitations.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, swelled up, On an unknown date the outcome of events, got a little red, On an unknown date the outcome of events, swollen again, On an unknown date the outcome of events, hot, On an unknown date the outcome of events, itchy, On an unknown date the outcome of events, round, On an unknown date the outcome of events, 3.5-inch circular rash, On an unknown date the outcome of events, fever, On an unknown date the outcome of events, palpitations was not reported.
High fever for 2 days followed by chills and profuse sweating. Severe case of  Shingles developed after 9 days.
Received expired second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired second dose) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037f21a and 014F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired second dose). On 01-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received expired second dose) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications was reported. Treatment information was not provided.  This case was linked to MOD-2021-347607, MOD-2021-347368 (Patient Link).
Initial shot (right arm) - Pt had to urinate every hour. Pt reports losing 5 pounds overnight. Immediately, my arm was in pain, it was hard to move. Ever since that day I had pain in my right arm. I saw my doctor (March 3rd) and he referred me for x-rays on my right arm, and it was determined that I had a torn rotator cuff and a detached right bicep.   Second shot (left arm) - Within 5 minutes of receiving the second shot pain stated in my upper arm at the injection site and it radiated down to the elbow.  Patient  also experience dizziness at this time. The pain lasted for 3-4 weeks but eventually went away.
Bruising at the injections site.  Began day after vaccination.  Continued to get larger patient presented to pharmacy 11 days after vaccination with bruising the size of a silver dollar. Advised patient to apply ice and follow up after the weekend.
This spontaneous report as received from a pharmacist refers to a 81 year old female patient with penicillin allergy. The patient had no pertinent medical history. On 08-OCT-2013 the patient was vaccinated with PNEUMOVAX 23 (lot # J004332, expiration date 26-SEP-2013) 0.5 ml, intramuscular for prevention of pneumonia. Concomitant therapies included CELEBREX and vitamin d (unspecified). On 09-OCT-2013, the patient experienced redness, warmth and puffiness just below the injection site, after received PNEUMOVAX 23. No treatment was received for the adverse events. The outcome of redness, warmth and puffiness just below the injection site was not reported. The relationship between PNEUMOVAX 23 and the events was not reported. Patient sought medical attention: Called pharmacist. Additional information has been requested.
Tingling Sensation in Head; Light Headed; Brain Fog; Increased Heart Rate - While Sleeping; Chills; Arm/Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of COLD-STIMULUS HEADACHE (Brain Fog), HEART RATE INCREASED (Increased Heart Rate - While Sleeping), PARAESTHESIA (Tingling Sensation in Head), DIZZINESS (Light Headed) and CHILLS (Chills) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEART RATE INCREASED (Increased Heart Rate - While Sleeping), CHILLS (Chills) and ARTHRALGIA (Arm/Joint Pain). On 23-Jan-2021, the patient experienced COLD-STIMULUS HEADACHE (Brain Fog), PARAESTHESIA (Tingling Sensation in Head) and DIZZINESS (Light Headed). On 26-Jan-2021, HEART RATE INCREASED (Increased Heart Rate - While Sleeping), PARAESTHESIA (Tingling Sensation in Head), DIZZINESS (Light Headed), CHILLS (Chills) and ARTHRALGIA (Arm/Joint Pain) had resolved. At the time of the report, COLD-STIMULUS HEADACHE (Brain Fog) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Very limited information regarding this events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Painful shingles like rash on right hip/waist area. By 5/3 pain has started to subside and rash redness and soreness appears to be subsiding.
Within 24 hours, fever, severe malaise, and arthralgia.  Administered 07/22/2003.  Symptoms are continuing to worsen.
dizzy; very weak and tired; very weak and tired; Left arm is killing her and can't do anything with it; This is a spontaneous report from a contactable consumer (patient) via the Pfizer sponsored program . A female patient of an unspecified age received the second dose of bnt162b2, via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2, via an unspecified route of administration on 17Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Patient received the second dose on 19Mar2021 and after getting the shot (Mar2021), she said her Left arm is killing her and can't do anything with it. And yesterday (04Apr2021) she also felt dizzy, very weak and tired. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Noticed rash on left thigh on 7/31/01. Afebrile. Varicella given on 7/17/01 and had vesicular lesions in semi-circle. No treatment necessary. Seen in office on 8/3/01. Vesicles crusted over.
Intense tingling, prickly and numb feeling in all toes and both feet, especially when seated or lying down;  It?s been 8 months and no sign of improvement.
My shoulder got sore and it was continuous sore, It is still sore to this day. I can not lay on my left side anymore. I started having heart palpitations within 15-16 days after and lasted for 3 months. My doctor could hear the palpitation with his stethoscope. I was extremely exhausted for 2-3 months. My doctor prescribed me Wellbutrin, I had a reaction to Wellbutrin. I was put on Cymbalta for pain.
This 78 year old female received the Covid shot on  1/29/21    and went to the ED and admitted on 4/7/21    with the following diagnoses listed below. U07.1 - COVID-19 J12.82 - Pneumonia due to Coronavirus disease 2019 J18.9 - Pneumonia R65.10 - SIRS (systemic inflammatory response syndrome) (CMS/HCC)
Booster shot, I had a Migraine like headache for 30 hours. I was unable to take any medicine as I am having a prostate examination on Thursday October 21, at the request of the doctor.
TEN DAYS AFTER RECEIVING THE MODERNA VACCINE, PATIENT COMPLAINS THAT HER IMMUNE SYSTEM HAS BEEN COMPROMISED. SHE IS COMPLAINING OF EAR AND NOSE INFECTION (STATES THAT SHE IS NEVER SICK). PATIENT COMPLAINS OF LIP BEING NUMB/SWOLLEN AND HAS SWOLLEN LEGS AND BRUISING. SHE ALSO STATES THAT SHE HAS NO APPETITE BUT WHEN SHE EATS SHE VOMITS. SHE IS CONSTANTLY NAUSEOUS AND HAS TINGLING IN HER FINGERS.
Pfizer -BIV GL0087 was given as 1st dose. Per patient she has not received any other covid vaccines prior to this immunization.
FEVER; DON'T FEEL GOOD; HEADACHE; DEHYDRATED; FREEZING; This spontaneous report received from a patient concerned a 40 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included type 1 diabetic. The patient was previously treated with for vitamin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination.vaccinated at 11:30 pm in right deltoid. No concomitant medications were reported. On 31-MAR-2021, the subject experienced fever. On 31-MAR-2021, the subject experienced don't feel good. On 31-MAR-2021, the subject experienced headache. On 31-MAR-2021, the subject experienced dehydrated. On 31-MAR-2021, the subject experienced freezing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, don't feel good, headache, dehydrated and freezing was not reported. This report was non-serious.
Patient thought it was dry skin, so he put lotion on. Then it kind of itched; Patient thought it was dry skin, so he put lotion on; welts; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Patient thought it was dry skin, so he put lotion on. Then it kind of itched), DRY SKIN (Patient thought it was dry skin, so he put lotion on), URTICARIA (welts) and RASH (rash) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (Patient thought it was dry skin, so he put lotion on. Then it kind of itched), DRY SKIN (Patient thought it was dry skin, so he put lotion on), URTICARIA (welts) and RASH (rash). At the time of the report, PRURITUS (Patient thought it was dry skin, so he put lotion on. Then it kind of itched), DRY SKIN (Patient thought it was dry skin, so he put lotion on), URTICARIA (welts) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medication included unspecified lotion.
No adverse reactions. Patient notified. Patient given 0.25mL of Moderna Bivalent booster dose.
TOOK VIVOTIF RIGHT AFTER DINNER; This spontaneous case report was received from a consumer (PVX2019-342) on 07-Feb-2019. The report describes a female consumer who "took Vivotif after dinner". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis for trip.  It was reported that the consumer took the first dose of Vivotif right after dinner instead of on an empty stomach.  The action taken with Vivotif with respect to the event "took Vivotif after dinner" was not applicable.  The clinical outcome of the event "took Vivotif after dinner" was unknown.  Company's Comment: The causality of the event "took Vivotif after dinner" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif after dinner" was considered as not applicable.
FEVER, DIARRHEA, HEADACHE, CHILLS, SORE ARM. PATIENT DID NOT GO TO DR. JUST SLEPT, TOOK TYLENOL AND LET ADVERSE REACTIONS RUN ITS COURSE FOR 24 HOURS.. IF PATIENT WOULD HAVE CALLED AT TIME OF RXN, WOULD HAVE TOLD HER TO USE COLD COMPRESS FOR ARM FOR 15 MIN, ;;LIE DOWN, APPLY COLD COMPRESS ALSO FOR THE ITCHY ARM FOR 15 MIN, TAKE BENADRYL AND WATCH FOR THE SIGNS OF ANAPHLAXIS,
Papular rash that started 10 days after vaccine on hand of arm that vaccine was received in. Got progressively worse over 10 days and then began to improve
dispensed a dose from recall batch; dispensed a dose from recall batch; This case was reported by a pharmacist via call center representative and described the occurrence of recalled drug administered in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number 9lh3y, expiry date 7th February 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On 30th June 2021, unknown after receiving Shingrix, the patient experienced drug dispensing error. On an unknown date, the patient experienced recalled drug administered. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The pharmacist reported that, their pharmacy dispensed a dose of Shingrix on 30th June 2021 from the recall batch, which led to recalled drug administered and drug dispensing error. The vaccine was meant to be administrated to a male patient but the facility was unaware of the date of the administration. The adverse event report came from a pharmacy who dispensed doses of the vaccine to other health institutions. The Shingrix doses were administrated in another facility and the reporter did not know when (exact date) or if the vaccines were in fact administrated, they only had the date in which the vaccines were dispensed from the pharmacy which were after the date of the Shingrix recall. The reporter of the adverse event did not know if the patients had adverse events after the administration of the vaccine. No further events were reported. The reporter consented to follow up. This case was linked with US2021202999 and US2021202998, reported by the same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021202998:same reporter US-GLAXOSMITHKLINE-US2021202999:same reporter
arm pain; Drug dose administration interval too long; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in July 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by the patient who herself was a Retired Nurse. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.   Follow up information received from the nurse on 3rd June 2019. The reporter had spoken with her pharmacist in last contact and the pharmacist advised the patient that she did not need to restart the series of Shingrix. On 31st May 2019, the patient received 2nd dose of Shingrix, which was delayed than the recommended schedule, which led to lengthening of vaccination schedule. Less than a week after receiving 2nd dose of Shingrix, the patient experienced her arm was hurting from the 2nd dose. At the time of report, the arm was still hurting, but was improving. It was unknown if the reporter considered the arm pain to be related to Shingrix administration.
2 inch diameter red circle around the injection right lasting 3 days, area was warm to touch and very sensitive.    Joint pain, joints ached with movement for 48 hours after injection. Mild muscle pain for 24 hours after injection.   Fatigue lasting whole day, the day after injection. Neck pain at base of skull started 48 hours after injection, lasted for 48 hours.
Patient c/o L deltoid pain, the night of the immunization. Patient was seen in the office the following day. His left arm was swelling and erythema. DX with allergic reaction to ProQuad. Given RX for Keflex and OTC Benadryl. Return in 1 week.
Pt recvd 1st dose of Hep B on 6MAR91 & on 7MAR91 devel facial paresthesia & muscle weakness in arms & legs; exp necessitated a visit to ER;
Blood pressure has dropped drastically; I also have bouts of dizziness; This case was reported by a consumer via interactive digital media and described the occurrence of blood pressure decreased in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced blood pressure decreased and dizziness. On an unknown date, the outcome of the blood pressure decreased and dizziness were unknown.   It was unknown if the reporter considered the blood pressure decreased and dizziness to be related to Shingrix.     Additional Information: GSK receipt date: 18-June-2022 Reporter's comment: The patient self-reported the case via interactive digital media. The patient recently had a shot and his/her blood pressure dropped drastically. The patient also had bouts of dizziness. The patient inquired if it was normal. Additional supportive information: Follow-up would not possible as no contact details were available.
Patient called pharmacy on 1/22/203 at approx. 5:20 pm stating that he started developing hives and itching the next day that started on feet and moved to his hands. After doing an internet search regarding the adverse effects of Shingrix, he wanted to know if I, as a pharmacist could offer any other suggestions to treat the hives. He started taking Diphenhydramine and took a cool shower.  He was told that he was doing everything that I would have suggested and said he should follow up with his primary doctor.  A follow up phone call on 1/24/2023 found that he had hives and sores all over his body but quickly resolved and his last dose of Diphenhydramine was 1/23/23 at noon.
At first, normal flu like symptoms and fatigue, low grade fever - like everyone else and to be expected for 24 hours and then that subsided.  Then shortly after within the same week of the vaccine I noticed subtle things like difficulty bringing my arm up to brush my teeth.  I could do it but it was like I was fighting my body to do so.  Symptoms increasingly got worse and more symptoms were noticed and they are as follows: Difficulty typing, difficulty writing, dizziness, difficulty walking - gait off and difficulty getting to a standing position, extreme weakness in my legs (had to stop driving), difficulty holding items and felt like I was going to drop things as I was very weak in my arms, chest pain, emotional extreme fatigue, I had a short bout of time of nauseau, uncomfortable/painful feeling in my chest...felt like things were swelling, my voice kept changing, waves of feeling like I was powering down, when I laid down...I would feel like I was going to pass out so I would sleep sitting up in a recliner, felt like I was in a fog, emotional and would cry over nothing (so not like me at all...typically a happy person), felt like my body was fighting me all the time.  This started as subtle signs and increasingly got worse with more and more signs and symptoms coming on for two months.  On July 7th, I took a nap in the afternoon and when I woke up I noticed a significant difference.  The dizziness was gone.  I continued over the next couple of weeks to slowly improve.  My doctor's were contributing this to low thyroid levels.  However, when I had the same reaction after the second Moderna vaccine I am thinking that perhaps it is a result of the vaccine.  I will submit a second document for my symptoms after the second vaccine.  I feel like my body over reacts after the vaccine and it exasperates signs and symptoms of my current medical issues (low thyroid symptoms and inflammatory condition as a result of having Covid in January of 2021) and in addition new symptoms show up such as the neurological issues as well.  When discussed with my doctor my thoughts on my body overreacting and this being a result of the vaccine, she too thought it is a possibility.
Patient called on 9/5/15 in the morning to inform me of her immunization. She states that her arm where Boostrix was administered is red, swollen, and painful. She said her MD gave her antibiotics.
varicella macules over trunk arms & face;no scabbing when seen;dx mild chickenpox/vaccine failure;
It is very red/ 4 inches long/ 3 inches wide/ It is big; Swelled up/ raised up, big knot under it; Itching really bad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (It is very red/ 4 inches long/ 3 inches wide/ It is big), VACCINATION SITE LYMPHADENOPATHY (Swelled up/ raised up, big knot under it) and VACCINATION SITE PRURITUS (Itching really bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. A39904, 010A21A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (It is very red/ 4 inches long/ 3 inches wide/ It is big), VACCINATION SITE LYMPHADENOPATHY (Swelled up/ raised up, big knot under it) and VACCINATION SITE PRURITUS (Itching really bad). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (It is very red/ 4 inches long/ 3 inches wide/ It is big), VACCINATION SITE LYMPHADENOPATHY (Swelled up/ raised up, big knot under it) and VACCINATION SITE PRURITUS (Itching really bad) outcome was unknown.      Following to vaccination, patient had side effects. The patient stated that 2 inches below the injection site, it was very red, 4 inches long, 3 inches wide- was big, red, swelled up, raised up, big knot under it, and stated that it is itching really bad. The patient stated that she took Tylenol for these discomfort and stated "no" for concomitant medications. No relevant concomitant medications was reported.
Information has been received from a registered nurse concerning a child pt who in mid August 2003 was vaccinated with a dose of varicella virus vaccine live. On approximately 07OCT2003, the pt developed a vesicular rash of more than 50 lesions over the body. Unspecified medical attention was sought, but treatment was not required. A product quality complaint was not involved.  Additional info has been requested.